Takeda Pharmaceutical TAK
NYSE TAK
$18.48 -0.42 (-2.22%)
As of: Sep 29, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Total Debt (2017 - 2026)

Updated

Takeda Pharmaceutical's Total Debt was $690.85 million in the quarter ended Jun 30, 2026, down 51.3% from $1.42 billion a year earlier and down 97.6% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Total Debt (2017 - 2026) Analysis & Trends

As of Mar 31, 2026, Total Debt at Takeda Pharmaceutical came in at $29.97 billion, up 9.1% from the prior year.

  • Total Debt shows a five-year compound annual growth rate of -8.2% (years ended Mar 2021 to Mar 2026).
  • In earlier years, Total Debt was $27.48 billion in the year ended Mar 31, 2025 (-14.2%), $32.04 billion in the year ended Mar 31, 2024 (+2.4%), $31.3 billion in the year ended Mar 31, 2023 (-19.0%) and $38.63 billion in the year ended Mar 31, 2022 (-15.8%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Total Debt since the quarter ended Nov 29, 2019.
  • Compared with a year earlier, Total Debt was higher in three of the last eight quarters, with an average decline of 11.2%.
  • The best year-over-year quarter for Total Debt over five years was the quarter ended Sep 30, 2023 (growth of 160.1%); the worst was the quarter ended Jun 30, 2026 (a decline of 51.3%).
  • Per Business Quant data, TAK's Total Debt in the three quarters before the quarter ended Jun 30, 2026 was $28.76 billion (quarter ended Mar 31, 2026), $1.76 billion (quarter ended Dec 31, 2025) and $1.53 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Takeda Pharmaceutical 2.74 Bn -23.77 Bn 5.10 Bn 690.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 690.85 Mn
Mar 31, 2026 28.76 Bn
Dec 31, 2025 1.76 Bn
Sep 30, 2025 1.53 Bn
Jun 30, 2025 1.42 Bn
Mar 31, 2025 27.43 Bn
Dec 31, 2024 1.42 Bn
Sep 30, 2024 1.36 Bn
Jun 30, 2024 1.70 Bn
Mar 31, 2024 31.17 Bn
Dec 31, 2023 1.68 Bn
Sep 30, 2023 2.13 Bn
Jun 30, 2023 2.29 Bn
Mar 31, 2023 31.97 Bn
Dec 31, 2022 1.28 Bn
Sep 30, 2022 818.75 Mn
Jun 30, 2022 1.08 Bn
Mar 31, 2022 37.32 Bn
Jun 30, 2021 2.13 Bn
Mar 31, 2021 45.93 Bn
API Access

Takeda Pharmaceutical Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=TAK&period=max&api_key=YOUR_API_KEY